HSA approves 11 applications for Sinopharm vaccine under Special Access Route
·1-min readDoses of the Chinese Sinopharm vaccine against COVID-19 (PHOTO: Reuters)SINGAPORE — The Health Sciences Authority (HSA) has approved multiple applications for private hospitals or clinics to bring in the Chinese-made Sinopharm vaccine via the Special Access Route (SAR) scheme.
In response to media queries byYahoo News Singapore, the authority on Friday (30 July) said that 11 such applications, including for clinics under IHH Healthcare Singapore, have been approved as of Wednesday."The risks of using COVID-19 vaccines approved under SAR are fully borne by the doctor and vaccine recipient," the HSA added.
The Sinopharm is the second Chinese-made vaccine to be made available in Singapore via the SAR scheme after Sinovac's CoronaVac vaccine.Those who have received the CoronaVac vaccine locallyare not included in Singapore's national vaccination numbers headtopics.com
. As of Wednesday, 95,029 doses of the China-made vaccine have been administered to 71,810 individuals.Under the SAR scheme for COVID-19 vaccines, private healthcare providers can apply to the HSA to bring in COVID-19 vaccines that are listed on the World Health Organisation’s Emergency Use Listing, for use by the doctors of that healthcare provider on patients under their care for specified needs.
Other COVID-19 vaccines listed by WHO are those made by Pfizer-BioNTech, AstraZeneca, and Moderna.Currently, only the Pfizer-BioNTech/Comirnaty and Moderna vaccines are part of Singapore's national vaccination programme. Read more: Yahoo Singapore »
Covid-19: S’pore ‘neither reversing nor racing ahead’ with reopening but pausing to slow, monitor spread, say ministers
SINGAPORE — In the face of questions over the progress of Singapore’s reopening amid a recent surge in Covid-19 cases, Health Minister Ong Ye Kung said on Friday (Sept 10) that the country is neither “reversing” nor “racing ahead” but will take the next two to four weeks to slow down transmission and monitor the rise in infections.
Ask yourself why Xi Jinping himself hasn't taken Sinovac or Sinopharm. Speaks volumes S'pore made it clear that unless those allergic to Pfizer/Moderna, they are to pay & responsible for hospital stays for their 'preferred' brands. This will allows more to be vaccinated yet without incurring cost + out of the blames for not approving these 'preferred' brands
Singapore smart. Few Singaporeans except the 450K Chinese National working in S'pore will want Sinovac. They 'sold' their 200K sinovac stock purchased by a bet, getting their money back instead of donating them, Sinopharm is a similar alternative. This time no money spent.
Covid-19: 11 private healthcare groups get HSA approval to import China’s Sinopharm vaccineSINGAPORE — The Health Sciences Authority (HSA) said it has approved 11 applications by local private healthcare groups to bring China’s Sinopharm Covid-19 vaccine into Singapore through its Special Access Route.
Covid-19: At least 2 private healthcare groups get approval to import China’s Sinopharm vaccineChina’s Sinopharm vaccine could be available in Singapore soon, with at least two private healthcare institutions here having gotten the green light from the Health Sciences Authority (HSA) to import it through a special route for as-yet-approved Covid-19 vaccines.
How anti-vaxxers triggered another, deadlier Covid wave in the USUS again reels from another spike in COVID-19 cases, putting pressure on health officials and hospitals and leaving the president practically begging people to get vaccinated.
Pfizer hikes 2021 outlook after vaccine boosts sales, profitStrong sales of its COVID-19 vaccine and other medicines helped Pfizer nearly double its second-quarter revenue and boost its profit an impressive ... 🤔
Google will require COVID-19 vaccine for US employees to step into campusesAlphabet Inc's Google said on Wednesday it would require employees in the United States to be vaccinated for stepping into its campuses, in an ...
Facebook warns growth to slow significantly, mandates vaccine for US staff:Facebook Inc said on Wednesday it expects revenue growth in the third and fourth quarters to 'decelerate significantly,' sending the social media ...